A citation-based method for searching scientific literature

Tremika Le-Shan Wilson, Namita Hattangady, Antonio Marcondes Lerario, Carmen Williams, Erika Koeppe, Shane Quinonez, Jenae Osborne, Kelly B Cha, Tobias Else. Fam Cancer 2017
Times Cited: 21







List of co-cited articles
250 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
198
66

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
217
66

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
Oriol Calvete, Paula Martinez, Pablo Garcia-Pavia, Carlos Benitez-Buelga, Beatriz Paumard-Hernández, Victoria Fernandez, Fernando Dominguez, Clara Salas, Nuria Romero-Laorden, Jesus Garcia-Donas,[...]. Nat Commun 2015
84
61

Germline mutations in shelterin complex genes are associated with familial glioma.
Matthew N Bainbridge, Georgina N Armstrong, M Monica Gramatges, Alison A Bertuch, Shalini N Jhangiani, Harsha Doddapaneni, Lora Lewis, Joseph Tombrello, Spyros Tsavachidis, Yanhong Liu,[...]. J Natl Cancer Inst 2014
130
57

The wide spectrum of POT1 gene variants correlates with multiple cancer types.
Oriol Calvete, Pablo Garcia-Pavia, Fernando Domínguez, Gaelle Bougeard, Kristin Kunze, Andreas Braeuninger, Alex Teule, Adriana Lasa, Teresa Ramón Y Cajal, Gemma Llort,[...]. Eur J Hum Genet 2017
35
47

POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
M Potrony, J A Puig-Butille, M Ribera-Sola, V Iyer, C D Robles-Espinoza, P Aguilera, C Carrera, J Malvehy, C Badenas, M T Landi,[...]. Br J Dermatol 2019
13
76

Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.
Daniel Chubb, Peter Broderick, Sara E Dobbins, Matthew Frampton, Ben Kinnersley, Steven Penegar, Amy Price, Yussanne P Ma, Amy L Sherborne, Claire Palles,[...]. Nat Commun 2016
83
42

Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
Helen E Speedy, Ben Kinnersley, Daniel Chubb, Peter Broderick, Philip J Law, Kevin Litchfield, Sandrine Jayne, Martin J S Dyer, Claire Dearden, George A Follows,[...]. Blood 2016
49
38

Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Kim Wong, Carla Daniela Robles-Espinoza, David Rodriguez, Saskia S Rudat, Susana Puig, Miriam Potrony, Chi C Wong, James Hewinson, Paula Aguilera, Joan Anton Puig-Butille,[...]. JAMA Dermatol 2019
15
53

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
100
33

Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.
Mary L McMaster, Chongkui Sun, Maria T Landi, Sharon A Savage, Melissa Rotunno, Xiaohong R Yang, Kristine Jones, Aurélie Vogt, Amy Hutchinson, Bin Zhu,[...]. Br J Haematol 2018
21
33

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
Andrew J Ramsay, Víctor Quesada, Miguel Foronda, Laura Conde, Alejandra Martínez-Trillos, Neus Villamor, David Rodríguez, Agnieszka Kwarciak, Cecilia Garabaya, Mercedes Gallardo,[...]. Nat Genet 2013
185
33

Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
Melissa A Richard, Philip J Lupo, Lindsay M Morton, Yutaka A Yasui, Yadav A Sapkota, Michael A Arnold, Geraldine Aubert, Joseph P Neglia, Lucie M Turcotte, Wendy M Leisenring,[...]. PLoS One 2020
10
70

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
257
28

Germline TERT promoter mutations are rare in familial melanoma.
Mark Harland, Mia Petljak, Carla Daniela Robles-Espinoza, Zhihao Ding, Nelleke A Gruis, Remco van Doorn, Karen A Pooley, Alison M Dunning, Lauren G Aoude, Karin A W Wadt,[...]. Fam Cancer 2016
28
23

Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.
Cristina Pellegrini, Maria Giovanna Maturo, Claudia Martorelli, Mariano Suppa, Ambra Antonini, Dimitra Kostaki, Lucilla Verna, Maria Teresa Landi, Ketty Peris, Maria Concetta Fargnoli. Melanoma Res 2017
20
25

Update in genetic susceptibility in melanoma.
Miriam Potrony, Celia Badenas, Paula Aguilera, Joan Anton Puig-Butille, Cristina Carrera, Josep Malvehy, Susana Puig. Ann Transl Med 2015
89
23

Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.
Alexandra M Pinzaru, Robert A Hom, Angela Beal, Aaron F Phillips, Eric Ni, Timothy Cardozo, Nidhi Nair, Jaehyuk Choi, Deborah S Wuttke, Agnel Sfeir,[...]. Cell Rep 2016
62
23



Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
Sudheer Kumar Gara, Li Jia, Maria J Merino, Sunita K Agarwal, Lisa Zhang, Maggie Cam, Dhaval Patel, Electron Kebebew. N Engl J Med 2015
91
23

Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Marco Capezzone, Silvia Cantara, Stefania Marchisotta, Sebastiano Filetti, Maria Margherita De Santi, Benedetta Rossi, Giuseppe Ronga, Cosimo Durante, Furio Pacini. J Clin Endocrinol Metab 2008
60
23


NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer.
Aida Orois, Sudheer K Gara, Mireia Mora, Irene Halperin, Sandra Martínez, Rocio Alfayate, Electron Kebebew, Josep Oriola. Genes (Basel) 2019
7
71

Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.
Mei He, Brent Bian, Krisana Gesuwan, Neelam Gulati, Lisa Zhang, Naris Nilubol, Electron Kebebew. Thyroid 2013
16
31

Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Feng Ye, Hongwei Gao, Lin Xiao, Zhixiang Zuo, Yueping Liu, Qi Zhao, Huijiao Chen, Weiyi Feng, Bo Fu, Linyong Sun,[...]. Int J Cancer 2019
21
23

Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
C D Malchoff, M Sarfarazi, B Tendler, F Forouhar, G Whalen, V Joshi, A Arnold, D M Malchoff. J Clin Endocrinol Metab 2000
146
23

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
19

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
Thomas P Potjer, Sander Bollen, Anneliese J E M Grimbergen, Remco van Doorn, Nelleke A Gruis, Christi J van Asperen, Frederik J Hes, Nienke van der Stoep. Int J Cancer 2019
24
19

How shelterin protects mammalian telomeres.
Wilhelm Palm, Titia de Lange. Annu Rev Genet 2008
19

Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
P Gu, Y Wang, K K Bisht, L Wu, L Kukova, E M Smith, Y Xiao, S M Bailey, M Lei, J Nandakumar,[...]. Oncogene 2017
31
19

The POT1-TPP1 telomere complex is a telomerase processivity factor.
Feng Wang, Elaine R Podell, Arthur J Zaug, Yuting Yang, Paul Baciu, Thomas R Cech, Ming Lei. Nature 2007
469
19

POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end.
Dirk Hockemeyer, Agnel J Sfeir, Jerry W Shay, Woodring E Wright, Titia de Lange. EMBO J 2005
216
19

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
19

Structural and functional analysis of the human POT1-TPP1 telomeric complex.
Cory Rice, Prashanth Krishna Shastrula, Andrew V Kossenkov, Robert Hills, Duncan M Baird, Louise C Showe, Tzanko Doukov, Susan Janicki, Emmanuel Skordalakes. Nat Commun 2017
49
19

Human CST promotes telomere duplex replication and general replication restart after fork stalling.
Jason A Stewart, Feng Wang, Mary F Chaiken, Christopher Kasbek, Paul D Chastain, Woodring E Wright, Carolyn M Price. EMBO J 2012
134
19

The human CST complex is a terminator of telomerase activity.
Liuh-Yow Chen, Sophie Redon, Joachim Lingner. Nature 2012
199
19

Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.
Silvia Cantara, Serena Capuano, Marco Capezzone, Michele Benigni, Milena Pisu, Stefania Marchisotta, Furio Pacini. Thyroid 2012
13
30

Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.
Julius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, Jon G Jonasson, Asgeir Sigurdsson, Jon T Bergthorsson, Huiling He, Thorarinn Blondal, Frank Geller, Margret Jakobsdottir,[...]. Nat Genet 2009
287
19

Endocrine tumours: familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis.
Xiaofei Wang, Wenli Cheng, Jingdong Li, Anping Su, Tao Wei, Feng Liu, Jingqiang Zhu. Eur J Endocrinol 2015
35
19

Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families.
Insoo Suh, Sebastiano Filetti, Menno R Vriens, Marlon A Guerrero, Salvatore Tumino, Mariwil Wong, Wen T Shen, Electron Kebebew, Quan-Yang Duh, Orlo H Clark. Surgery 2009
36
19


Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
Joana S Pereira, Joana Gomes da Silva, Rute Alexandra Tomaz, António Evaristo Pinto, Maria João Bugalho, Valeriano Leite, Branca Maria Cavaco. Endocrine 2015
37
19


Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
110
19

A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition.
Jerneja Tomsic, Huiling He, Keiko Akagi, Sandya Liyanarachchi, Qun Pan, Blake Bertani, Rebecca Nagy, David E Symer, Benjamin J Blencowe, Albert de la Chapelle. Sci Rep 2015
53
19

Familial non-medullary thyroid cancer: unraveling the genetic maze.
Samantha Peiling Yang, Joanne Ngeow. Endocr Relat Cancer 2016
56
19

A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.
Huiling He, Wei Li, Daniel F Comiskey, Sandya Liyanarachchi, Taina T Nieminen, Yanqiang Wang, Katherine E DeLap, Pamela Brock, Albert de la Chapelle. Thyroid 2020
13
30

A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
F Canzian, P Amati, H R Harach, J L Kraimps, F Lesueur, J Barbier, P Levillain, G Romeo, D Bonneau. Am J Hum Genet 1998
179
19

Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
G R Bignell, F Canzian, M Shayeghi, M Stark, Y Y Shugart, P Biggs, J Mangion, R Hamoudi, J Rosenblatt, P Buu,[...]. Am J Hum Genet 1997
158
19


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.